Am J Perinatol 2022; 39(08): 861-868
DOI: 10.1055/s-0040-1719079
Original Article

Charge Nurses Taking Charge, Challenging the Culture of Culture-Negative Sepsis, and Preventing Central-Line Infections to Reduce NICU Antibiotic Usage

Samarth Shukla
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
Josef Cortez
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
Bill Renfro
2   Department of Pharmacy, University of Florida Health, Jacksonville, Florida
,
Kartikeya Makker
3   Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
,
Colleen Timmons
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
P. Sireesha Nandula
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
Rita Hazboun
4   Division of Neonatology, Children's Hospital of Richmond, Virginia Commonwealth University, Richmond, Virginia
,
Rima Dababneh
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
Cristina Hoopes
5   Department of Women's and Children's Nursing Services, University of Florida Health, Jacksonville, Florida
,
Jenny VanRavestein
5   Department of Women's and Children's Nursing Services, University of Florida Health, Jacksonville, Florida
,
Yvette McCarter
6   Department of Pathology and Laboratory Medicine, University of Florida Health, Jacksonville, Florida
,
Marilyn Middlebrooks
7   Department of Infection Prevention and Control, University of Florida Health, Jacksonville, Florida
,
Ma Ingyinn
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
,
Ana Alvarez
8   Division of Infectious Diseases and Immunology, University of Florida College of Medicine, Jacksonville, Florida
,
Mark L. Hudak
1   Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
› Institutsangaben
Preview

Abstract

Objective We aimed to reduce our monthly antibiotic usage rate (AUR, days of treatment per 1,000 patient-days) in the neonatal intensive care unit (NICU) from a baseline of 330 (July 2015–April 2016) to 200 by December 2018.

Study Design We identified three key drivers as follows: (1) engaging NICU charge nurses, (2) challenging the culture of culture-negative sepsis, and (3) reducing central-line associated bloodstream infections (CLABSI). Our main outcome was AUR. The percentage of culture-negative sepsis that was treated with antibiotics for >48 hours and CLABSI was our process measure. We used hospital cost/duration of hospitalization and mortality as our balancing measures.

Results After testing several plan-do-study-act (PDSA) cycles, we saw a modest reduction in AUR from 330 in the year 2016 to 297 in the year 2017. However, we did not find a special-cause variation in AUR via statistical process control (SPC) analysis (u'-chart). Thereafter, we focused our efforts to reduce CLABSI in January 2018. As a result, our mean AUR fell to 217 by December 2018. Our continued efforts resulted in a sustained reduction in AUR beyond the goal period. Importantly, cost of hospitalization and mortality did not increase during the improvement period.

Conclusion Our sequential quality improvement (QI) efforts led to a reduction in AUR. We implemented processes to establish a robust antibiotic stewardship program that included antibiotic time-outs led by NICU charge nurses and a focus on preventing CLABSI that were sustained beyond the QI period.

Key Points

  • This is a quality improvement project to reduce antibiotic usage in NICU.

  • Charge nurses should take charge to reduce infections in NICU.

  • Central line infections should be reduced to decrease antibiotic usage.

Note

Institutional Review Board at University of Florida Health Jacksonville (UFHJ) approved this initiative as a QI project. Any sensitive health information was not shared or disclosed outside UFHJ.




Publikationsverlauf

Eingereicht: 03. April 2020

Angenommen: 24. September 2020

Artikel online veröffentlicht:
03. November 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA